SDSynectic Product Development logo

Synectic Product Development

Unclaimed
synectic.netWoodbridge, CT

ISO 13485-certified, full-service product development partner delivering end-to-end design, prototyping, and manufacturing services.

Overview

Synectic Product Development is an ISO 13485-certified, full-scale product development company. Vertically integrated within the Mack Group, its capabilities span concept-to-production design, prototyping, testing, and regulatory documentation, with over 40 years of experience in design, development, and manufacturing. The firm serves medical devices, military/defense, robotics, consumer products, capital equipment, and related industries, delivering end-to-end, cost-conscious, and aesthetically oriented solutions.

Mission statement

To turn bold ideas into manufacturable products through integrated design, engineering, and manufacturing services, delivering high-quality, cost-effective solutions that meet market needs.

What we offer

EKKO Acoustic Cell Processing System

Revolutionizes cell and gene therapy manufacturing with closed-loop processing and real-time feedback.

synectic.net/cell-processing-capital-equipment/

Virtual Incision Robotic Surgery End Effectors

Enhances surgical precision and safety with versatile, miniaturized disposable tools for robotic surgery.

synectic.net/end-effectors-for-robotic-surgery/

PūrGo Air Filter

Efficiently reduces airborne pathogens and particulates with FDA-cleared UV-C technology.

synectic.net/commercial-air-purifier/

End-to-End Product Development

Service

Delivering comprehensive product development services from concept to market readiness with seamless integration.

synectic.net/product-development-company/

Product Design Services

Service

Transform concepts into manufacturable designs that are functional and visually appealing.

synectic.net/product-design-services/

Market segments

Market size by segment

Growth potential (CAGR)

Cell therapy processing equipment

1.8 Billion USD12.5% CAGR

Capital and single-use cartridge-based systems that automate cell separation, concentration, and processing for cell and gene therapy manufacturing.

Robotic surgical instruments

7.9 Billion USD15% CAGR

Miniaturized, single-use end effectors and bipolar instruments for robot-assisted surgery designed for electrical isolation, ISO 60601 compliance, and precise tissue manipulation.

Medical-grade air purification devices

1.05 Billion USD10% CAGR

FDA-cleared UV-C LED and filtration-based air disinfection and particulate reduction devices designed, documented, and packaged for regulated clinical environments.

Contract product development and manufacturing

70 Billion USD7% CAGR

Vertically integrated, ISO 13485-capable end-to-end product design, prototyping, regulatory documentation, and manufacturing transfer services for medical devices and industrial products.

More information about our offering

EKKO Acoustic Cell Processing System

Capital equipment cell processor that uses ultrasonic waves to separate solids from liquids for cell and gene therapy manufacturing. Integrates a capital unit with a single-use disposable cartridge and a carefully engineered fluid path. Includes weight and temperature feedback, in-house firmware, and high-level control software to support streamlined production.

  • Ensures Closed-Loop Processing
    This integration promotes a sterile environment essential for cell and gene therapy applications.
  • Enables Advanced Cell Manipulation
    Ultrasonic processing techniques provide superior outcomes compared to traditional methods, enhancing cell therapy results.
  • Delivers Accurate Fluid Management
    Pinch valves enable exact control of fluid movements, enhancing processing efficiency.
  • Facilitates User-Friendly Operation
    The intuitive interface simplifies user interaction, allowing for smooth operation and monitoring.
  • Offers Real-Time Operational Insights
    These sensors monitor crucial parameters, ensuring optimal performance and immediate troubleshooting when necessary.

Virtual Incision Robotic Surgery End Effectors

Family of single-use disposable end effectors for robot-assisted surgery capable of grasping, sealing, cutting, and dissecting. Designed to be extremely small and isolated to meet ISO 60601 testing, with minimized dead space and biocompatible materials.

  • Prevents Short Circuits
    This feature is crucial for patient safety, ensuring that the device does not malfunction during use.
  • Performs Multiple Functions
    This integration simplifies surgical procedures by reducing the number of tools required.
  • Meets Safety Standards
    Compliance ensures that the devices are safe for use in medical settings.
  • Enables Precise Manipulation
    The miniaturization helps surgeons navigate delicate procedures effectively.
  • Ensures Sterility
    This feature minimizes cross-contamination risk between patients.

PūrGo Air Filter

FDA-cleared air purifier using UV-C LED-based air purification technology to reduce particulates and pathogens. The device is packaged for sturdy shipping, produced in-house with full regulatory documentation, and transferred to Mack Group manufacturing.

  • Achieves Regulatory Compliance
    This FDA Class II clearance ensures that the air filter meets stringent safety and efficacy standards, which is crucial for customer trust and market access.
  • Improves Indoor Air Quality
    This advanced purification method effectively minimizes harmful airborne substances, enhancing health and comfort for users.
  • Ensures Quality Control
    The initial production phase allows for meticulous quality checks and thorough documentation, assuring customers of the product’s reliability.
  • Facilitates Scale-Up
    The design allows for a smooth transition to mass manufacturing, ensuring consistent availability for the market.
  • Promotes Safe Shipping
    The packaging not only protects the product during transport but also ensures compliance with regulatory standards.

End-to-End Product Development

Comprehensive product development service spanning strategy, design, prototyping, and manufacturing. Integrated within the Mack Group to deliver a seamless path from concept to production, with a single partner and a dedicated engineer as the project contact.

  • Ensures Consistency Across Phases
    Completing all development stages with a coordinated team minimizes miscommunication and errors.
  • Facilitates Fast Iteration and Adaptation
    Control over prototyping allows for quicker adjustments and iterations, resulting in a more refined final product.
  • Streamlines the Development Process
    Collaboration between design and manufacturing teams ensures manufacturability from the outset.
  • Enhances Communication
    Simplifies communication with a dedicated contact, ensuring clarity and focus throughout the project.
  • Secures Client Innovations
    Empowers clients by ensuring that all intellectual property developed during the process remains theirs.

Product Design Services

Design phase from concept sketches to production-ready CAD. Industrial design and engineering work together to deliver ergonomic, manufacturable products with CMF specifications and production-ready files.

  • Provides Comprehensive Design Solutions
    By integrating industrial design and engineering from the start, we ensure the design is both feasible and market-ready, maximizing efficiency and effectiveness.
  • Optimizes Manufacturing Costs
    Through a DFM approach, mitigates risks tied to production costs by designing with manufacturability in mind.
  • Creates Market-Ready Aesthetics
    Integrating industrial design within the engineering phase ensures a cohesive product that meets visual and functional demands.
  • Enhances User Experience
    Focus on ergonomic design ensures that products are user-friendly and safe for all end users.
  • Delivers High-Quality Design Files
    Provides comprehensive documentation and designs ready for prototype development and production.

References

Methodology and sourcing behind the market figures shown above.

Cell therapy processing equipment

Primary source (cell processing equipment market report snippet) indicates a current equipment market size of ~USD 1.8B (2024) with a projected CAGR ~12.5%. Broader cell therapy manufacturing and overall cell therapy market reports (PrecedenceResearch, BioSpace) show larger manufacturing and therapy market bases and higher CAGRs, supporting sustained demand for processing equipment and justifying a mid- to high-teens growth potential for equipment driven by therapy commercialization and manufacturing scale-up.

Robotic surgical instruments

Estimate derived by applying reported instruments & accessories share (55–68%) of the overall surgical-robotics market to published total-market figures (2024–2026). Overall market CAGRs reported across sources range ~6.7%–17.2%; instruments/consumables typically grow at or above platform rates due to recurring use, so a ~15% CAGR is used as a central estimate.

Medical-grade air purification devices

Estimate based on published market studies for adjacent segments. BCC Research reports the hospital air purifier market at $2.1B (2023) with 11.4% CAGR (2023–2028). Future Market Insights reports a narrower healthcare air purifier market at $333.7M (2025) with 4.8% CAGR (2025–2035). The medical-grade, FDA‑cleared subset is a portion of hospital/healthcare purifiers; using a midpoint allocation (≈50% of hospital purifier spend) yields ~USD 1.05B current market and a conservative growth projection near 10% CAGR, between the higher hospital-focused CAGR and lower healthcare-specific CAGR.

Contract product development and manufacturing

Estimation based on reported totals for broader contract manufacturing and CDMO markets in the search results. BCC reports global contract manufacturing at ~$648.5B (2024); healthcare/pharma CDMO reports range from ~$150B (2024) to ~$268B (2025) across sources. The target segment (ISO 13485-capable, end-to-end product development and manufacturing for medical devices and industrial products) is a specialized subset of overall contract manufacturing; applying a conservative share (~10–12%) of the broader contract-manufacturing/healthcare CDMO market yields an estimated market size ~USD 70B. CAGR aligned to the 7% range reported across sources for contract manufacturing/CDMO markets.

Behind this profile

This is a public preview. Whoever claims it decides what it shows.

This profile was built from public information. Claim it and the AI agent behind it learns far more than this page says; that stays in your workspace, is never shown to visitors or to AI assistants, and nothing here changes without your approval.

Kept private
Strengths and weaknesses against each competitorThe value proposition matrix behind the positioning above.
BattlecardsHow to win against a named competitor, persona by persona.
AI visibility and citationsWhere assistants mention Synectic Product Development, where they don't, and who they cite instead.
Site audit, keyword rankings and recommendationsWhat to fix so AI ranks Synectic Product Development higher.

Own this company? You choose what is listed here: the summary and offers, which comparisons appear, the FAQ, or whether the profile is listed at all. Unlisting takes one switch.

Claim this company's AI agent

This profile was built from public web sources. Is this your company? Take control → · Request removal →